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1   Introduction
Since the beginning of this century, an 
ever-greater proportion of personal and 
professional information has been digi-
tally archived by the business and public 
sectors, including by health care services. 
This increasing volume of data can take 
a variety of forms compiled in differing 
formats and with divergent properties. 
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Objectives: The paper draws attention to: i) key considerations 
involving the confidentiality, privacy, and security of shared 
data; and ii) the requirements needed to build collaborative 
arrangements encompassing all stakeholders with the goal of 
ensuring safe, secure, and quality use of shared data. 
Method: A narrative review of existing research and policy 
approaches along with expert perspectives drawn from the 
International Medical Informatics Association (IMIA) Working 
Group on Technology Assessment and Quality Development 
in Health Care and the European Federation for Medical 
Informatics (EFMI) Working Group for Assessment of Health 
Information Systems.
Results: The technological ability to merge, link, re-use, and 
exchange data has outpaced the establishment of policies, proce-
dures, and processes to monitor the ethics and legality of shared 
use of data. Questions remain about how to guarantee the security 
of shared data, and how to establish and maintain public trust 
across large-scale shared data enterprises. This paper identifies 
the importance of data governance frameworks (incorporating 
engagement with all stakeholders) to underpin the management 
of the ethics and legality of shared data use. The paper also 
provides some key considerations for the establishment of national 
approaches and measures to monitor compliance with best practice. 
Conclusion: Data sharing endeavours can help to underpin 
new collaborative models of health care which provide shared 
information, engagement, and accountability amongst all 
stakeholders. We believe that commitment to rigorous 
evaluation and stakeholder engagement will be critical to 
delivering health data benefits and the establishment of 
collaborative models of health care into the future.
Keywords
Confidentiality; computer security; informed consent; evidence-
based practice; program evaluation
Yearb Med Inform 2018:25-8
http://dx.doi.org/10.1055/s-0038-1641192
These types of data, generally referenced 
as big data, are typically characterised by 
their “V” properties, namely: volume (the 
amount of data), velocity (the speed of data 
transaction and accumulation), variety (the 
range of data types and sources), veracity 
(the trustworthiness of data sources), value 
(its relevancy to health topics), and variabil-
ity (the changing nature of health events) 
[1]. Additional “V” properties can include 
visualisation (representation) and volatility 
(how long the data are valid) [2]. Some view 
big data as essentially combining data from 
independent and very different sources, 
such as retail pharmacy over the counter 
(OTC) sales and primary care consultations, 
while pooled health data are seen differently 
as very large data, but for this paper the 
underlying issues are largely similar.
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The use of large shared data sources has 
the potential to improve our understanding 
of the breadth and course of health care de-
livery [3], by helping to: a) identify emerging 
health issues and the factors that contribute 
to medical conditions; b) assess the safety 
of treatment options; c) measure the effec-
tiveness and efficiency of health care [4, 5]; 
and d) improve practical and organisational 
effectiveness in delivery [6]. The expansion 
of shared data sources has also spurred the 
growth of personalised medicine with its 
promise of targeted molecular tests and ther-
apies, providing a bridge between the world 
of clinical practice and that of molecular 
bioinformatics [7]. 
Nevertheless, there are major concerns 
about the extent of community awareness 
and individual consent to the utilisation of 
large shared data enterprises. The techno-
logical ability to merge, link, re-use, and 
exchange data has outpaced the establish-
ment of policies, procedures, and processes 
to monitor the ethics and legality of shared 
use of data. Questions remain about how to 
guarantee the security of shared data [8], and 
how to establish and maintain public trust 
across large-scale shared data enterprises. 
2   An Evaluation Imperative
The delivery of health care has become in-
creasingly intertwined with the development 
and utilisation of new, more powerful, and 
more complex information systems. This 
means that the emergence of any problems 
associated with these systems (e.g. concerns 
about the quality and validity of data, and 
the security and privacy of information) is 
likely to impact on the provision of care and 
people’s well-being [9]. Recent examples of 
data breaches of high profile data, including 
ransomware cyber-attacks, can adversely 
affect public trust [10]. The digitisation of 
information in health systems is a global 
activity. As such its progress and outcomes 
need to be underpinned by the evaluation 
and generation of: i) evidence about its 
effectiveness, security, and trustworthiness; 
and ii) robust and validated governance (e.g., 
what is permitted?) and security (e.g., is it 
effectively protected?) mechanisms [11-13]. 
The International Medical Informatics 
Association (IMIA) Working Group (WG) 
for Technology Assessment and Quality 
Development and the European Federation 
for Medical Informatics (EFMI) Working 
Group for Assessment of Health Information 
Systems seek to raise awareness regarding 
evaluation as an essential activity required 
to protect all stakeholders (e.g. patients and 
health care professionals) confidentiality, 
privacy, security, and safety, stimulate op-
timisation, and enhance sustainability [14, 
15]. In a previous Yearbook submission [16], 
the WG enunciated some key evaluation 
considerations for secondary uses of clinical 
data, including describing a methodological 
framework for best practice. In this paper, 
we draw upon existing research and policy 
approaches to highlight a number of key 
evaluation considerations for establishing 
public trust in shared data involving:
• Privacy – an individual’s right to keep 
information to oneself and to consent to 
what information is collected and how it 
is used [17];
• Confidentiality – to prevent data from be-
ing exposed to unauthorised parties [18]; 
• Security – Confidentiality, integrity (the 
ability to ensure that data is an accurate and 
unchanged representation of the original 
secure information), and availability (data 
is accessible to those who are authorised 
to access/process/disclose) [18].
3   Data Governance 
Requirements
In 2017, the Organisation for Economic 
Cooperation and Development (OECD) re-
port “New Health Technologies – Managing 
Access, Value and Sustainability”, noted that 
the sharing of personal health data present-
ed a number of risks to individual privacy, 
which can undermine public confidence in 
social institutions [19]. Most of the risks of 
data misuse and threats to privacy occur not 
through the controlled sharing of data or in 
the release of non-identifiable data, but from 
hacking or other breaches that have exposed 
weaknesses in the collection, storage, secu-
rity, and management of data [4].
It is quite reasonable to assume that there 
may not be a means to completely guarantee 
the security of all systems. As a recent New 
England Journal of Medicine commentary 
by Gordon and colleagues noted, as long as 
there is value in information, we can expect 
to see attacks on the systems designed to 
protect security [9]. Our ability to recognise 
the nature and public health implications of 
these threats is therefore critically important 
to improving dialogue, incorporating the 
views of the individual (citizen, clinician, 
health professional), health care organi-
sations, and the broader community, and 
implementing the means to enhance trust 
and security [20]. 
Such considerations have prompted 
many to advocate for fundamental data 
governance structural changes to address 
today’s data sharing reality [4, 20, 21]. This 
involves major discussions about how data 
is collected, stored, aggregated, linked, and 
transmitted [22]. For instance, when data is 
collected and stored for future use, it is im-
possible to anticipate all the potential future 
uses [23]. Some of the broad criteria for data 
governance frameworks must include the 
need to deliver benefits to the community, 
increase the availability and usefulness of 
data, and engender stakeholder engagement 
and community trust and confidence about 
how data are managed and used [4]. 
Establishing stakeholder engagement 
means more than guaranteeing that people 
have a choice, and consent to the use of 
their own data. It also involves: i) ensuring 
that consent issues related to shared data are 
understood; ii) promoting public awareness 
about the uses of shared data; and iii) en-
gaging people in ongoing discussions about 
privacy, confidentiality, and security of shared 
data [8]. In this regard, the United Kingdom 
Department of Health has emphasized that the 
safe use of data and technology must include 
transparency about the governance of data, 
as a means of helping people make informed 
choices about the use of their data and its pro-
tection especially when dealing with sensitive 
and confidential personal health data [24].
The OECD Guidelines on the Protection of 
Privacy and Transborder Flows of Personal 
Data is one of the most widely recognised 
and commonly used privacy frameworks. 
Some core principles, such as collection 
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limitation, purpose specification, use limita-
tion, security safeguards, openness, individual 
participation, and accountability, have laid 
the groundwork for countries to design their 
own privacy and security guidelines. Revi-
sions undertaken in 2013 have incorporated 
national privacy strategies, privacy manage-
ment programmes, and data security breach 
notification into the framework [25]. 
Health information privacy measures 
should be devised to protect individuals’ 
interests and respect intrinsic values. The 
collection, storage, and use of personal 
information as well as the justifications for 
sharing data need to be closely scrutinised. 
For instance, there should be no disclosure 
of potential identifiers to unauthorised par-
ties. In some cases, pseudo-identities can 
be generated to replace the true identities to 
ensure the data can no longer be linked to 
their corresponding nominative identities. In 
every situation, it is essential to ensure min-
imal risk of assocating data with individual 
patient and staff identity. 
4   National Approaches to 
Monitoring Compliance with 
Evidence-based Best Practices
Generally, when large national health IT and/
or large-scale data sharing initiatives are an-
nounced, they are associated with the release 
of a benefit realisation framework designed to 
measure and enunciate the achievements of 
the initiative and plans. Many contemporary 
eHealth plans specify a data sharing element 
in their frameworks, considering either data 
sharing between health care providers or data 
sharing between health care providers and 
the patient. Thus, monitoring the existence 
and focus of these data sharing policies can 
provide a foundation for more detailed mea-
surement of data sharing (e.g. see also [26]). 
The prerequisite for establishing value 
in any data sharing exercise is that the data 
is available and usable by those who need 
it. When data is collected and stored for 
reuse in an electronic format, it is possible 
to examine usage logs to monitor who has 
accessed the data and the role (s)he per-
forms [27]. From a clinical perspective, 
data safety and security-related competence 
measures (including the ability to provide 
assurance of confidentiality, access con-
trol, and security) have been included in 
a number of clinical areas (e.g. the Tiger 
initiative) [28], and as part of the Finnish 
national usability survey for nurses [29]. 
Other relevant evaluation measures may 
include: a) the proportion of professionals 
having access to shared data; b) the number 
of patient visits where shared data are used; 
and c) the usability and user satisfaction 
involved with data sharing [30]. The pro-
portion of citizens experiencing trust as 
a barrier for sharing their health data has 
been monitored e.g., in Finland [31] as a 
citizen-focused measure. The status of the 
implementation of safety standards is one 
of the measures that provides a distinctive 
health care organisational viewpoint [32]. 
From a statistical and research angle, 
the secondary use of health information 
is regarded as one of the most promising 
outcomes of the sharing of health data, even 
despite the existence of barriers (including 
quality problems with the data) which 
may slow implementation [33]. There are 
numerous possible data quality measures, 
including the use of a consistent patient 
identifier, the completeness of the data 
(measured for example, by the population 
coverage of electronic clinical records and 
key datasets) [34], data timeliness, and the 
level of granularity of the data. Population 
coverage can be monitored by establishing 
the proportion of health care organisations 
or professionals having access to electronic 
sharing and their viewing of shared data [35]. 
Granularity can be monitored by mapping 
the use of coding and classifications in stored 
and shared data [36]. 
The Nordic eHealth indicator work 
has highlighted the challenges as well as 
the opportunities of developing common 
performance indicators for information 
exchange and data sharing from the clinical 
perspective. Developing indicators to mon-
itor access, quality, use, and value of shared 
data utilisation using Health Care Quality 
registers and data logs from national health 
information databases in addition to the 
survey data has been proposed as a next step 
in monitoring the safety and value of shared 
data utilisation [37].
5   Conclusion
The ongoing and dramatic developments in 
digital health are a big contributor to trans-
formative changes across the health care 
system. Large data sharing endeavours can 
help to underpin new collaborative models 
of health care which provide shared informa-
tion, engagement, and accountability across 
all stakeholders [38]. A robust commitment 
to evaluation is critical to delivering health 
data benefits and the establishment of col-
laborative models of health care well into 
the future. Some of the key evaluation con-
siderations for ensuring the success of data 
governance frameworks and the realisation 
of health data benefits include: i) stakeholder 
consultation that ensures that stakeholders’ 
views and values are adequately represented, 
e.g., by regularly monitoring usability and 
user satisfaction involved with (national) 
data sharing plans and implementations; ii) 
governance frameworks that are reviewed 
and renewed to reflect community values; 
and iii) the utilisation of current, best prac-
tice technologies, measures and methods 
to protect patient data privacy security and 
trustworthiness.
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